Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children - Wikidata - wikimedia - TriplyDB

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

http://www.wikidata.org/entity/Q33939018

about

Review of vancomycin-induced renal toxicity: an update Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients.Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.A Novel Method to Mask the Bitter Taste of Berberine Hydrochloride: Powder Surface Modification.

P2860

Q26746932-CD89ECD7-A595-4AE0-ACB9-202D1E08BFC8 Q36322918-22462300-0E8E-4B07-BFEE-A3C17BE08D0F Q38400067-57F4807C-4CC6-409A-9F89-5ADDF1758FBA Q39044128-35F9DFE0-EEAA-4BDF-A235-69851754D5EA Q40048536-27C99DFA-F2F9-467E-A97E-5A84C9888283 Q47164367-D7BA9E21-A99E-4120-A15A-23C36B83513E Q53688753-FD69B3B5-F672-4170-AD82-E12C2052D70A

P2860

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

http://www.wikidata.org/entity/Q33939018

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@ast

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@en

type

label

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@ast

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@en

prefLabel

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@ast

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@en

P1433

Q33939018-AA806C48-8EC5-47DD-BF4A-62CF5A72B508

P1476

Q33939018-5299C948-C34D-4993-B78F-4FD57CAA6435

P2093

Q33939018-9D512D47-7BE5-4BB7-A304-0233950D8CBC

Q33939018-C5E9784E-8E8B-4ACA-8EC2-BD03A8AB38B2

Q33939018-D86508DF-C624-47DB-A6E6-EDB192B8DEA5

P2860

Q33939018-09C82B72-24BD-4F19-8C9B-91248D0E4B5B

Q33939018-14A8BE24-D40B-4359-BFC9-A0601795ECC3

Q33939018-2D1F06F9-AA18-4DE1-B76B-48C53EF65C33

Q33939018-3D3F5295-922C-4BC3-AC0B-608FF066D278

Q33939018-3D63BB0E-7629-477A-97D1-2A0952CBD7CA

Q33939018-7C6274EE-CB6D-4847-ABD5-B772B5581917

Q33939018-82AD9436-5812-428D-AE28-DFA86C8D2713

Q33939018-89C206BD-39EE-43C8-9882-F65543A5A8AB

Q33939018-949DFBA4-DEED-4141-8AA7-5042F67C082C

Q33939018-B54F9ADC-46DF-4A06-BF76-A761D5A8A1E4

P2888

Q33939018-438A46DB-09A6-467E-9027-E66E8E3C944C

P304

Q33939018-B75CA0EE-544B-4258-88B0-12A7E6071A21

P31

Q33939018-CB2B8195-D546-4E50-854E-FC39E6C2169C

P356

Q33939018-EB99444F-E376-4F7B-8A96-62CA61C58375

P433

Q33939018-57B6DFD0-52E5-49B3-B4FA-82F4C90EF9C0

P478

Q33939018-DD858A25-3117-47F3-9BFF-F5C0B883BA73

P577

Q33939018-5CD7164B-5386-42FD-98A0-006864E50CE6

P5875

Q33939018-774FABAF-8642-49A9-8D9B-92DA5293D404

P6179

Q33939018-14880C45-DD40-4591-B4DB-F8C45E7E5C88

P698

Q33939018-65ECB25B-5068-48B6-A51F-9D94CD388372

P932

Q33939018-F65062E2-139A-4243-B03C-F6E101794C15

P356

S40121-013-0004-8

P1433

Infectious diseases and therapy

P1476

Incidence and predisposing factors of vancomycin-induced nephrotoxicity in children

@en

P2093

Ahmed R Ragab

http://www.w3.org/2001/XMLSchema#string

Maha K Al-Mazroua

http://www.w3.org/2001/XMLSchema#string

Mona A Al-Harony

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States.

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity

Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.

The risk of determining risk with multivariable models.

Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.

Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?

P2888

s40121-013-0004-8

P304

37-46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-013-0004-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257809040

http://www.w3.org/2001/XMLSchema#string

P6179

1033950678

http://www.w3.org/2001/XMLSchema#string

P698

25135822

http://www.w3.org/2001/XMLSchema#string

P932

4108093

http://www.w3.org/2001/XMLSchema#string